IP Library Granted Patent US 11,344,382
Granted Patent B2
US 11,344,382 · App. 15/113,703 · Granted May 31, 2022

Systems and methods comprising localization agents

Inventors: Laura G King (Brookfield, WI); Daniel W. Van Der Weide (Madison, WI); Fred T. Lee, Jr. (Madison, WI)
Assignee: ELUCENT MEDICAL, INC.
A61B90/39A61B5/062A61B5/064A61B90/90A61B90/98A61B2090/3908A61B2090/3929A61B2090/3945A61B2090/3958A61B2090/3991
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,344,382
App. No.
15/113,703
Granted
May 31, 2022
Kind
B2
Abstract

Provided herein are systems and methods comprising localization agents. For example, provided herein are systems and methods for the placement of localization devices within biological systems and the detection of such localization devices for targeted surgeries or other medical procedures. For example, provided herein are systems comprising one or more miniature detectable devices that are placed into a target location and activated by remote introduction of a magnetic field.

Claims (15)

1. A method for activating and locating a tag that is in a tumor, or a tissue region near said tumor, of a patient, comprising:

(a) positioning the patient with the tumor in an imaging device and determining a location of said tumor with said imaging device;

(b) introducing the tag into said tumor, or said tissue region near said tumor, through an introduction device such that said tag is embedded in said tissue region or tumor,

wherein said tag is at least partially covered in a biocompatible material; and wherein said tag comprises a radio-frequency identification (RFID) chip;

(c) activating said tag by generating an alternating magnetic field at an excitation frequency with an excitation coil that is in a pad positioned beneath the patient such that said tag generates a signal at a tag frequency different than the excitation frequency in response to said alternating magnetic field; and

(d) detecting said signal from the tag using a lock-in amplifier.

2. The method of claim 1 , wherein said introduction device comprises an introduction needle.

3. The method of claim 1 , wherein said introduction device comprises a cannula or an endoscope.

4. A system comprising:

(a) a localization tag comprising a radio-frequency identification (RFID) chip, wherein said localization tag is at least partially covered in a biocompatible material;

(b) tag delivery needle configured for delivering said localization tag into a tumor or a tissue of a patient such that said localization tag is configured to be embedded in said tumor;

(c) a pad, comprising an excitation coil, wherein said pad is configured to be placed on an operating table and below a patient in order to generate an alternating magnetic field at an excitation frequency that penetrates the patient to excite a signal from said localization tag at a tag frequency different than the excitation frequency;

(d) a hand-held component configured to display the presence of said localization tag; and

(e) a lock-in amplifier to detect the signal from said localization tag.

5. The system of claim 4 , wherein the tag frequency is a harmonic of the excitation frequency.

Assignments (2)
SECURITY INTEREST Recorded Nov 3, 2024
From: ELUCENT MEDICAL, INC.
To: TRINITY CAPITAL INC., AS COLLATERAL AGENT
Reel/Frame 069116/0736 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2016
From: KING, LAURA G.; VAN DER WEIDE, DANIEL W.; LEE, FRED T., JR
To: ELUCENT MEDICAL, INC.
Reel/Frame 039946/0001 →
Continuity (2)
Provisional Application 61931395 · Jan 24, 2014
Related Publication 20170007352A1 · Jan 12, 2017